🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EEG Monitoring for Refractory Status Epilepticus

RecruitingNAAges 16 Years - anyAllBarts & The London NHS Trust
NCT04170491 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective randomized study to investigate the yield of continuous electroencephalogram (cEEG), as a diagnostic tool in intensive care unit (ICU), for patients with refractory status epilepticus (RSE) and the contribution of this test to the patient final outcome, compared with standard medical care. Specifically, the hypothesis is that the use of cEEG for patients with RSE will significantly reduce the length of in-hospital stay, mortality, and subsequent complications (such as infections or pressure ulcers). It is also predicted that quality of life will be higher following cEEG at 0, 3, 6 and 12 months after discharge. As there are currently no data available from previous studies assessing the impact of cEEG on markers of the final clinical outcome in patients with RSE, this study is going to start as a feasibility study, aiming to obtain initial data for the primary outco

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Patients aged \> 16 years * Consent obtained according to Mental Capacity Act 2005 * Patients admitted to ICU for treatment of status epilepticus or admitted for another reason and diagnosed with SE during their admission * Convulsive Status epilepticus defined by either: * Tonic-clonic SE lasting longer than 5 minutes, * Focal SE with impaired consciousness lasting longer than 10 minutes * or Non-Convulsive SE according to Salzburg consensus criteria * Status epilepticus that continues despite treatment with benzodiazepine and one antiepileptic medication Exclusion Criteria: * Anoxic brain injury
💊

What it tests

  • Continuous EEG
📍

Where

1 site
Royal London Hospital
London, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy